Supplement Ingredient Supply Trends Can Shed Light On Adulteration
This article was originally published in The Tan Sheet
Executive Summary
The sudden abundance of formerly scarce raw ingredients for dietary supplements may signal economically motivated adulteration
You may also be interested in...
Ingredient Safety Concerns Rise Among FDA Enforcement Priorities
Ingredient safety, new dietary ingredient notifications, adverse event reporting, claims substantiation and disease claims are all drawing FDA attention in the supplement space, Daniel Fabricant says. Compliance for good manufacturing practices still heads the priorities for enforcement, he says.
Ingredient Safety Concerns Rise Among FDA Enforcement Priorities
Ingredient safety, new dietary ingredient notifications, adverse event reporting, claims substantiation and disease claims are all drawing FDA attention in the supplement space, Daniel Fabricant says. Compliance for good manufacturing practices still heads the priorities for enforcement, he says.
GAO Adulteration Report Points To Disconnect Among FDA Offices
Food and drug attorneys critique the Government Accountability Office’s report on FDA’s efforts to counter economically motivated adulteration, which calls for greater cross-agency collaboration.